Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis

Aim: to evaluate the efficacy and duration of the therapeutic effect of dequalinium chloride (in comparison with clindamycin) in treatment of vaginal dysbiosis. Materials and methods. A total of 73 fertile-aged women (18-35 years old) with abnormal vaginal microbiota were examined. The patients were...

Full description

Saved in:
Bibliographic Details
Main Authors: A. B. Khuraseva, T. V. Reminnaya
Format: Article
Language:Russian
Published: IRBIS LLC 2018-11-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/508
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849697359172206592
author A. B. Khuraseva
T. V. Reminnaya
author_facet A. B. Khuraseva
T. V. Reminnaya
author_sort A. B. Khuraseva
collection DOAJ
description Aim: to evaluate the efficacy and duration of the therapeutic effect of dequalinium chloride (in comparison with clindamycin) in treatment of vaginal dysbiosis. Materials and methods. A total of 73 fertile-aged women (18-35 years old) with abnormal vaginal microbiota were examined. The patients were randomized into two groups: Group 1 (main) included 37 women receiving dequalinium chloride; Group 2 (control) included 36 women under clindamycin therapy. The efficacy was assessed by analyzing patients’ complaints, by gynecological examinations, pH values of the vaginal fluid, the Amsel criteria, the microscopy results and the polymerase chain reaction (PCR). Results. Before the treatment, the Amsel criteria were positive in 36 patients (97.29%) in the main group and in 31 patients (93.93%) in the control group; all patients showed an increase in the pH values of the vaginal fluid by more than 4.5 units. The state of vaginal microbiocenosis as evaluated with RT-PCR diagnostics (Femoflor 16 analysis) identified a variety of gram-positive and gram-negative bacteria with a marked decrease in the number of Lactobacilli. During the treatment period, there were no complaints of adverse events; pH values were normal in all patients; the Femoflor 16 analysis showed a significant decrease in the amounts of pathogenic microorganisms. As assessed in 1 month after the treatment, the therapeutic effect persisted. Conclusion. The dequalinium chloride has antibacterial effect on bacterial vaginosis. The results of the study showed that dequalinium chloride had the efficacy comparable with that of clindamycin.
format Article
id doaj-art-6760c7bebfc847a8acd92dd090f6d5e8
institution DOAJ
issn 2313-7347
2500-3194
language Russian
publishDate 2018-11-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj-art-6760c7bebfc847a8acd92dd090f6d5e82025-08-20T03:19:14ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942018-11-01123293410.17749/2313-7347.2018.12.3.029-034465Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosisA. B. Khuraseva0T. V. Reminnaya1Kursk State Medical University, Health Ministry of Russian FederationKursk State Medical University, Health Ministry of Russian FederationAim: to evaluate the efficacy and duration of the therapeutic effect of dequalinium chloride (in comparison with clindamycin) in treatment of vaginal dysbiosis. Materials and methods. A total of 73 fertile-aged women (18-35 years old) with abnormal vaginal microbiota were examined. The patients were randomized into two groups: Group 1 (main) included 37 women receiving dequalinium chloride; Group 2 (control) included 36 women under clindamycin therapy. The efficacy was assessed by analyzing patients’ complaints, by gynecological examinations, pH values of the vaginal fluid, the Amsel criteria, the microscopy results and the polymerase chain reaction (PCR). Results. Before the treatment, the Amsel criteria were positive in 36 patients (97.29%) in the main group and in 31 patients (93.93%) in the control group; all patients showed an increase in the pH values of the vaginal fluid by more than 4.5 units. The state of vaginal microbiocenosis as evaluated with RT-PCR diagnostics (Femoflor 16 analysis) identified a variety of gram-positive and gram-negative bacteria with a marked decrease in the number of Lactobacilli. During the treatment period, there were no complaints of adverse events; pH values were normal in all patients; the Femoflor 16 analysis showed a significant decrease in the amounts of pathogenic microorganisms. As assessed in 1 month after the treatment, the therapeutic effect persisted. Conclusion. The dequalinium chloride has antibacterial effect on bacterial vaginosis. The results of the study showed that dequalinium chloride had the efficacy comparable with that of clindamycin.https://www.gynecology.su/jour/article/view/508bacterial vaginosisdequalinium chlorideclindamycinvaginal biocenosis
spellingShingle A. B. Khuraseva
T. V. Reminnaya
Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
Акушерство, гинекология и репродукция
bacterial vaginosis
dequalinium chloride
clindamycin
vaginal biocenosis
title Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
title_full Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
title_fullStr Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
title_full_unstemmed Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
title_short Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
title_sort efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
topic bacterial vaginosis
dequalinium chloride
clindamycin
vaginal biocenosis
url https://www.gynecology.su/jour/article/view/508
work_keys_str_mv AT abkhuraseva efficacyofdequaliniumchloridevaginaltabletsintreatmentofbacterialvaginosis
AT tvreminnaya efficacyofdequaliniumchloridevaginaltabletsintreatmentofbacterialvaginosis